KARENITECIN Trademark

Trademark Overview

On Tuesday, May 18, 2004, a trademark application was filed for KARENITECIN with the United States Patent and Trademark Office. The USPTO has given the KARENITECIN trademark a serial number of 78420571. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, April 12, 2016. This trademark is owned by Bionumerik Pharmaceuticals, Inc.. The KARENITECIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, medications used in the treatment of cancer and antiviral medications
karenitecin

General Information

Serial Number78420571
Word MarkKARENITECIN
Filing DateTuesday, May 18, 2004
Status800 - REGISTERED AND RENEWED
Status DateTuesday, April 12, 2016
Registration Number3013179
Registration DateTuesday, November 8, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2005

Trademark Statements

Goods and Servicespharmaceuticals, namely, medications used in the treatment of cancer and antiviral medications

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 25, 2004
Primary Code005
First Use Anywhere DateMonday, December 21, 1998
First Use In Commerce DateMonday, December 21, 1998

Trademark Owner History

Party NameCROWN BIOSCIENCE, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92127
Party NameBionumerik Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78230
Party NameBionumerik Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229
Party NameBionumerik Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229

Trademark Events

Event DateEvent Description
Tuesday, May 25, 2004NEW APPLICATION ENTERED
Friday, December 17, 2004ASSIGNED TO EXAMINER
Friday, December 17, 2004NON-FINAL ACTION WRITTEN
Friday, December 17, 2004NON-FINAL ACTION E-MAILED
Friday, January 14, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 14, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 28, 2005PAPER RECEIVED
Monday, March 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 13, 2005AMENDMENT FROM APPLICANT ENTERED
Saturday, April 16, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 22, 2005ASSIGNED TO LIE
Wednesday, July 27, 2005NOTICE OF PUBLICATION
Tuesday, August 16, 2005PUBLISHED FOR OPPOSITION
Thursday, April 28, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 10, 2011TEAS SECTION 8 & 15 RECEIVED
Monday, July 25, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 30, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 12, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, November 8, 2005REGISTERED-PRINCIPAL REGISTER
Saturday, July 30, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Thursday, February 4, 2016TEAS SECTION 8 & 9 RECEIVED
Tuesday, April 12, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 12, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, April 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 12, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 1, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, November 8, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 2, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

karenitecin medications cancer antiviral treatment used namely pharmaceuticals